Stability Comparison of TIVA and Sevoflurane in Prone Spinal Surgery(TIVA:Total Intravenous Anesthesia)

Saglik Bilimleri Universitesi

Status: Completed

Conditions: Spinal Stenosis, Lumbosacral Region

Treatments: Drug: TIVA; Drug: Sevoflurane

Study type: Interventional

Funder types: Other

Identifiers

NCT06558695

SaglikBilimleriU-KLKSH-Anes-01

Details and patient eligibility

About

Key Points:

1. Objective:

   o To compare the effects of Total Intravenous Anesthesia (TIVA) and sevoflurane anesthesia on respiratory mechanics, hemodynamic parameters, and neuromonitoring during prone position spinal surgeries.

2. Methodology:

   • A randomized controlled trial involving 52 patients scheduled for lumbar spine surgery, randomly assigned to either TIVA or sevoflurane groups.
   • Respiratory and hemodynamic parameters were measured at various time points.

3. Results:

   • No significant differences were found between the TIVA and sevoflurane groups in terms of respiratory mechanics or hemodynamic stability.
   • Both anesthesia techniques maintained stable intraoperative conditions.

4. Clinical Implications:

   • Anesthesiologists can flexibly choose between TIVA and sevoflurane based on patient-specific factors and surgical requirements.
   • TIVA may be preferred in surgeries with high neurological risk due to its compatibility with neuromonitoring.

5. Future Research:

   • Studies with broader patient populations and long-term outcomes are needed to further refine anesthesia management strategies.
   • Research on the environmental impact and cost-effectiveness of anesthesia techniques is also important.

Full description

This study aims to evaluate the impact of total intravenous anesthesia (TIVA) versus sevoflurane anesthesia on respiratory mechanics and hemodynamic parameters during spinal surgery performed in the prone position. Anesthesia management for spinal surgeries in the prone position is particularly challenging due to significant physiological changes. Identifying the effects of different anesthesia techniques is essential to enhance patient outcomes and ensure intraoperative stability. This randomized controlled trial involved 52 patients scheduled for lumbar spine surgery under general anesthesia. Participants were randomly allocated to either the TIVA group (n=26) or the sevoflurane group (n=26). Measurements of respiratory mechanics, including peak airway pressure (Ppeak), mean airway pressure (Pmean), positive end-expiratory pressure (PEEP), end-tidal CO2 (ETCO2), tidal volume (VT), respiratory rate (RR), and minute ventilation (MV), were taken at various intervals. Hemodynamic parameters such as systolic and diastolic blood pressures and heart rate were continuously monitored.

Enrollment: 52 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• The study included male and female patients aged 18 to 65 years who were scheduled for lumbar spine surgery under general anesthesia. Patients were categorized based on the American Society of Anesthesiologists (ASA) physical status levels I, II, and III.

Exclusion criteria

• Diagnosis of asthma or chronic obstructive pulmonary disease (COPD)
• Major cardiac conditions, such as recent myocardial infarction or a left ventricular ejection fraction (EF) less than 55%
• Atrioventricular blocks of second and third degrees
• Allergies to any drugs
• Severe neurological disorders
• History of sedative or opioid use

Trial design

Primary purpose: Screening

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

52 participants in 2 patient groups

Sevoflurane Group

Active Comparator group

Description:

In the Sevoflurane group, general anesthesia was maintained with sevoflurane at 0.8-1.0 minimum alveolar concentration (MAC).

Treatment:

Drug: Sevoflurane

TIVA group

Active Comparator group

Description:

In the TIVA (Total Intra Venous Anesthesia) group, a combination of propofol (50-150 μg/kg/min) and remifentanil (0.02-0.2 μg/kg/min) was used for general anesthesia instead of inhalational agents.

Treatment:

Drug: TIVA